Infant deaths due to heparin overdose: time for a concerted action on prevention

Paul Monagle1, David M Studdert, Fiona Newall

  • 1Department of Clinical Haematology, The Royal Children's Hospital, Melbourne, Victoria, Australia. paul.monagle@rch.org.au

Insights

Heparin use in children needs safer practices. Despite research on its use, many fatal heparin errors occur, highlighting the urgent need for strategies to prevent infant deaths.

Area of Science:

  • Pediatric pharmacology and patient safety.
  • Anticoagulant therapy in children.

Background:

  • Heparin is a widely used anticoagulant in pediatric tertiary care centers.
  • Significant research has focused on evidence-based recommendations for pediatric heparin use and management.
  • There is a notable lack of focus on improving the safe administration of heparin in children.

Purpose of the Study:

  • To highlight the critical need for improved strategies to ensure the safe use of heparin in infants and children.
  • To address the disparity between research on heparin efficacy and research on heparin safety in pediatric populations.

Main Methods:

  • Review of existing literature and reported incidents concerning heparin use in pediatric patients.
  • Analysis of the gap in research focusing on safety protocols versus therapeutic guidelines for pediatric heparin administration.

Main Results:

  • Numerous fatal and non-fatal heparin-related errors in pediatric patients have been reported.
  • Despite advancements in understanding heparin's therapeutic applications, preventable errors continue to pose significant risks.

Conclusions:

  • There is an urgent and unmet need for coordinated efforts to develop and implement strategies for minimizing heparin-related errors in infants and children.
  • Concerted action is required to improve patient safety and prevent avoidable deaths associated with heparin therapy in pediatric care.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...